We’re pleased to announce a renewed province-wide membership agreement with N2 (Network of Networks).
Continue reading “N2 province-wide membership renewed for 2023-2024”
We’re pleased to announce a renewed province-wide membership agreement with N2 (Network of Networks).
Continue reading “N2 province-wide membership renewed for 2023-2024”
The US Federal Drug Administration released a new draft document titled ‘Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers” on March 12, 2023
Questions: What is the definition of a true or certified copy in Canada? Are we allowed to transfer the Clinical Trial Essential Records from the original medium to another media during the study and at the time of archive?
These team-funded programs mobilize communities for research impact — supporting co-development of research questions and disseminating research evidence to audiences who can directly use it. Continue reading “Competitions open: 2023 Convening & Collaborating (C2) and Reach Programs”
We’re calling for proposals to support a review of the impact of our 20-year history funding research talent.
Continue reading “Evaluation of Scholar and Research Trainee talent development”
We will provide support to UBC’s new Immuno-Engineering and Biomanufacturing Hub.
Continue reading “Partnering with UBC on Canada’s Immuno-Engineering and Biomanufacturing Hub”
The field of bioprinting holds great promise for human health. Health Research BC awardee, Dr. Stephanie Willerth’s innovative work in this area will ultimately improve health outcomes for people with neurological diseases.
Along with our partners, we are co-funding exceptional research talent who are giving hope to people living with neurological diseases and disorders.
Continue reading “Partnerships boost next generation of BC’s neuroscience researchers”
People using data in BC will benefit from expanded access to a data management tool: REDCap.
Continue reading “Data tool now available for more BC health projects”
Question: Do investigators and institutions have to provide direct access to source data and documents related to a clinical trial monitoring, REB review, audits, and regulatory inspection?
Continue reading “ASK JEAN Column: direct access to source data and documents”